CSIMarket
 
Novanta Inc   (NASDAQ: NOVT)
 
Price: $147.2400 $2.72 1.882%
Day's High: $147.7100067138672 Week Perf: 3.54 %
Day's Low: $ 142.15 30 Day Perf: -3.84 %
Volume (M): 270,068 52 Wk High: $ 176.38
Volume (M$): $ 0 52 Wk Avg: $132.24
Open: $144.84 52 Wk Low: $98.27



 Market Capitalization (Millions $) 6,060
 Shares Outstanding (Millions) 41
 Employees 3,000
 Revenues (TTM) (Millions $) 1,005
 Net Income (TTM) (Millions $) 54
 Cash Flow (TTM) (Millions $) 283
 Capital Exp. (TTM) (Millions $) 15

Business Description


Novanta Inc. is a leading technology company that designs and manufactures innovative photonics, vision, and precision motion components and subsystems for advanced manufacturing and medical automation markets. The company was founded in 1968 and is headquartered in Bedford, Massachusetts.

Novanta specializes in providing customized solutions to its customers in the medical and industrial markets. The company's key business segments include Photonics, Vision, and Precision Motion. The Photonics segment designs and manufactures high-performance optical systems and components to enable laser-based materials processing and metrology. The Vision segment designs and manufactures complete vision systems for medical and industrial applications. The Precision Motion segment designs and manufactures precision motion components and subsystems for medical and other high-precision applications.

The company operates through a network of global locations, with its major operations in North America, Europe, and Asia. The company has over 2,500 employees worldwide, supported by a strong research and development team that continuously works to develop new and innovative products.

Novanta has established itself as a trusted partner to many of the world's largest and most successful companies in their respective markets. The company's market-leading products and solutions are known for their quality, reliability, and innovation. Novanta's commitment to sustainability and social responsibility is demonstrated through its unique corporate responsibility program, which focuses on environmental stewardship, social inclusion, and ethical business practices.

In summary, Novanta Inc. is a highly innovative technology company that designs and manufactures photonics, vision, and precision motion components and subsystems for advanced manufacturing and medical automation markets. The company operates through a global network of locations, has over 2,500 employees worldwide, and is committed to sustainability and social responsibility.


   Company Address: 125 Middlesex Turnpike Bedford 1730 MA
   Company Phone Number: 266-5700   Stock Exchange / Ticker: NASDAQ NOVT


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
NNBR   -3.08%    
• View Complete Report
   



Business Update

Novanta Inc. Amplifies Share Repurchase Strategy A Signal of Confidence in a Tumultuous Market,

Published Fri, Sep 19 2025 9:17 AM UTC

Novanta Inc. Bolsters Share Repurchase Programme Amidst Market Challenges: A Testament to Long-Term Confidence In a significant development for investors and stakeholders alike, Novanta Inc. (Nasdaq: NOVT), a distinguished technology partner to medical and advanced technology equipment manufacturers, has announced an ambitious expansion of its share repurchase programme. The...

Business Update

BEDFORD, Mass. Novanta Inc. (Nasdaq NOVT) is set to make significant waves at Bairds upcoming 2024 Gl...

Published Tue, Aug 6 2024 12:47 AM UTC

Novanta Inc. Showcases Resilience at Baird’s 2024 Global Healthcare Conference Amid Mixed Quarter Results BEDFORD, Mass. Novanta Inc. (Nasdaq: NOVT) is set to make significant waves at Baird s upcoming 2024 Global Healthcare Conference, scheduled for September 10, 2024, in New York City. Matthijs Glastra, the company s Chair and Chief Executive Officer, will represent ...

Business Update

Novanta Inc. Set to Showcase Growth and Innovation at Bairds 2024 Global Healthcare Conference

Published Mon, Aug 5 2024 10:47 PM UTC

Novanta Inc. Anticipates Momentum at Baird s 2024 Global Healthcare Conference BEDFORD, Mass. Novanta Inc. (Nasdaq: NOVT), a preeminent technology partner to leading medical and advanced technology equipment manufacturers, is poised to present its strategic vision and impressive growth metrics at the Baird s 2024 Global Healthcare Conference on Tuesday, September 10, 2024,...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 104.43
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 6.03
Price to Sales (Expected) -
Price to Book 4.62
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.84
Working Capital Ratio 3.73
Leverage Ratio (MRQ) 0.36
Total Debt to Equity 0.18
Interest Coverage (TTM) 8.48
Debt Coverage (TTM) 0.43

Per Share Current
Earnings (TTM) 1.41 $
Revenues (TTM) 24.41 $
Cash Flow (TTM) 6.87 $
Cash 9.45 $
Book Value 31.85 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 334,836
Net Income per Employee (TTM) 17,907
Receivable Turnover Ratio (TTM) 5.82
Inventory Turnover Ratio (TTM) 3.07
Asset Turnover Ratio (TTM) 0.61

Profitability Ratios Current
Gross Margin (MRQ) 44.09 %
Operating Margin (MRQ) 10.69 %
Net Margin (MRQ) 8.19 %
Net Cash Flow Margin (MRQ) 3.08 %
Effective Tax Rate (TTM) 22.79 %

Management Effectiveness Current
Return On Assets (TTM) 3.29 %
Return On Investment (TTM) 3.69 %
Return On Equity (TTM) 5.08 %
Dividend Yield -
Pay out Ratio (TTM) -



Novanta Inc's Segments
Maximum Professional Services    0 % of total Revenue
Automation Enabling Technologies    50.95 % of total Revenue
Automation Enabling Technologies Precision Manufacturing    18.28 % of total Revenue
Automation Enabling Technologies Robotics and Automation    32.68 % of total Revenue
Medical Solutions    49.1 % of total Revenue
Medical Solutions Precision Medicine    24.82 % of total Revenue
Medical Solutions Advanced Surgery    24.28 % of total Revenue
United States    47.37 % of total Revenue
Germany    14.09 % of total Revenue
Rest of Europe    16.4 % of total Revenue
China    9.14 % of total Revenue
Rest of Asia-Pacific    10.63 % of total Revenue
Other Countries    2.42 % of total Revenue
Medical    0 % of total Revenue
Advanced Industrial    0 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.